sri 63-441 has been researched along with Shock, Septic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fei, X; Gong, XQ; Li, SH; Wu, ZL | 1 |
| Hsueh, W; Sun, XM; Torre-Amione, G | 1 |
2 other study(ies) available for sri 63-441 and Shock, Septic
| Article | Year |
|---|---|
Effects of platelet-activating factor antagonist SRI 63-441 on endotoxin-induced changes in rat mesenteric microcirculation.
Topics: Animals; Endotoxins; Escherichia coli; Female; Male; Microcirculation; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Shock, Septic; Splanchnic Circulation | 1991 |
Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
Topics: Animals; BCG Vaccine; Endotoxins; Gastrointestinal Diseases; Hypotension; Lipopolysaccharides; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Shock, Septic; Tumor Necrosis Factor-alpha; Zymosan | 1990 |